Literature DB >> 3831086

Short course treatment of paucibacillary (TT/BT) leprosy cases.

B K Girdhar, A Girdhar, G Ramu, K V Desikan.   

Abstract

A study has been undertaken wherein (TT/BT) cases with less than 5 lesions have been given DDS for 12 months alone or in combination with steroids for initial 1 month or rifampicin for initial one week. It has been found that only about three fourths of the cases become disease inactive in 12 months period. Follow up of 15 to 21 months in the post treatment period has shown a relapse rate of 6.33 per 1000 patient months. There was no difference in number of relapses occurring in the three regimens i.e. with or without rifampicin. Half the relapses were primarily in the nerves. During the course of treatment, a slightly higher number of patient in the DDS group had nerve problems as compared to group wherein additional steroids had been given.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3831086

Source DB:  PubMed          Journal:  Indian J Lepr        ISSN: 0254-9395


  2 in total

1.  Steroid prophylaxis for prevention of nerve function impairment in leprosy: randomised placebo controlled trial (TRIPOD 1).

Authors:  W Cairns S Smith; Alison M Anderson; Stephen G Withington; Wim H van Brakel; Richard P Croft; Peter G Nicholls; Jan Hendrik Richardus
Journal:  BMJ       Date:  2004-05-24

2.  BORDERLINE TUBERCULOID LEPROSY: CLINICOPATHOLOGICAL EVALUATION OF MULTIDRUG THERAPY.

Authors:  P K Kar; R S Dhaka
Journal:  Med J Armed Forces India       Date:  2017-06-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.